ARTICLES:

M. Gerlach, M.B.H. Youdim, and P. Riederer

Pharmacology of selegiline
Neurology 1996 47: 137S-145S. [Abstract] [Full Text] [Figures Only] [PDF]  

Werner H. Poewe and Gregor K. Wenning

The natural history of Parkinson's disease
Neurology 1996 47: 146S-152S. [Abstract] [Full Text] [Figures Only] [PDF]  

J. William Langston

The etiology of Parkinson's disease with emphasis on the MPTP story
Neurology 1996 47: 153S-160S. [Full Text] [PDF]  

Peter Jenner and C. Warren Olanow

Oxidative stress and the pathogenesis of Parkinson's disease
Neurology 1996 47: 161S-170S. [Abstract] [Full Text] [PDF]  

W. G. Tatton

Modulation of gene expression rather than monoamine oxidase inhibition: (-)-Deprenyl-related compounds in controlling neurodegeneration
Neurology 1996 47: 171S-183S. [Abstract] [Full Text] [PDF]  

Stanley Fahn

Is levodopa toxic?
Neurology 1996 47: 184S-195S. [Full Text] [Figures Only] [PDF]  

William C. Koller

Selegiline monotherapy in the treatment of Parkinson's disease
Neurology 1996 47: 196S-199S. [Full Text] [PDF]  

V. V. Myllyla, K. Sotaniemi, O. Maki-Ikola, U. K. Rinne, and E. H. Heinonen

Role of selegiline in combination therapy of Parkinson's disease
Neurology 1996 47: 200S-209S. [Full Text] [Figures Only] [PDF]  

C. Warren Olanow

Selegiline: Current perspectives on issues related to neuroprotection and mortality
Neurology 1996 47: 210S-216S. [Full Text] [Figures Only] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.